RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      Elective neck treatment in clinically node-negative paranasal sinus carcinomas: impact on treatment outcome

      한글로보기

      https://www.riss.kr/link?id=A105973151

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose: The indication of elective neck treatment (ENT) for clinically N0 (cN0) paranasal sinus (PNS) carcinoma remains unclear.
      We aimed to investigate different treatment outcomes regarding ENT and propose optimal recommendations for ENT.
      Materials and Methods: We identified patients with cN0 PNS carcinoma who underwent curative-intent treatment between 1992 and 2015. Survival outcomes and pattern of failure were compared between patients who received ENT and those who did not.
      We sought to identify significant patient or pathologic factors regarding treatment outcomes.
      Results: Among 124 patients meeting the inclusion criteria, 40 (32%) received ENT (‘ENT (+) group’) and 84 (68%) did not (‘ENT (−) group’). With a median follow-up of 54 months, the 5-year overall survival (OS) was 67%, and the 5-year progression-free survival (PFS) was 45%. There was no significant difference between the ENT (+) and ENT (−) groups regarding OS (p = 0.67) and PFS (p = 0.50). Neither group showed a significantly different pattern of failure, including regional failure (p = 0.91). There was no specific benefit, even in the subgroups analysis by tumor site, histologic type, and T stage. Nevertheless, patients who ever had regional and/ or distant failure showed significantly worse prognosis.
      Conclusion: ENT did not significantly affect the survival outcome or pattern of failure in patients with cN0 PNS carcinomas, showing that ENT should not be generalized in this group. However, further discussion on the optimal strategy for ENT should continue because of the non-negligible regional failure rates and significantly worse prognosis after regional failure events.
      번역하기

      Purpose: The indication of elective neck treatment (ENT) for clinically N0 (cN0) paranasal sinus (PNS) carcinoma remains unclear. We aimed to investigate different treatment outcomes regarding ENT and propose optimal recommendations for ENT. Materials...

      Purpose: The indication of elective neck treatment (ENT) for clinically N0 (cN0) paranasal sinus (PNS) carcinoma remains unclear.
      We aimed to investigate different treatment outcomes regarding ENT and propose optimal recommendations for ENT.
      Materials and Methods: We identified patients with cN0 PNS carcinoma who underwent curative-intent treatment between 1992 and 2015. Survival outcomes and pattern of failure were compared between patients who received ENT and those who did not.
      We sought to identify significant patient or pathologic factors regarding treatment outcomes.
      Results: Among 124 patients meeting the inclusion criteria, 40 (32%) received ENT (‘ENT (+) group’) and 84 (68%) did not (‘ENT (−) group’). With a median follow-up of 54 months, the 5-year overall survival (OS) was 67%, and the 5-year progression-free survival (PFS) was 45%. There was no significant difference between the ENT (+) and ENT (−) groups regarding OS (p = 0.67) and PFS (p = 0.50). Neither group showed a significantly different pattern of failure, including regional failure (p = 0.91). There was no specific benefit, even in the subgroups analysis by tumor site, histologic type, and T stage. Nevertheless, patients who ever had regional and/ or distant failure showed significantly worse prognosis.
      Conclusion: ENT did not significantly affect the survival outcome or pattern of failure in patients with cN0 PNS carcinomas, showing that ENT should not be generalized in this group. However, further discussion on the optimal strategy for ENT should continue because of the non-negligible regional failure rates and significantly worse prognosis after regional failure events.

      더보기

      참고문헌 (Reference)

      1 Kang JH, "Treatment outcomes between concurrent chemoradiotherapy and combination of surgery, radiotherapy, and/or chemotherapy in stage III and IV maxillary sinus cancer: multi-institutional retrospective analysis" 70 : 1717-1723, 2012

      2 Takes RP, "The controversy in the management of the N0 neck for squamous cell carcinoma of the maxillary sinus" 271 : 899-904, 2014

      3 Kuo P, "Survival outcomes for combined modality therapy for sinonasal undifferentiated carcinoma" 156 : 132-136, 2017

      4 Paulino AC, "Results of treatment of patients with maxillary sinus carcinoma" 83 : 457-465, 1998

      5 Jiang GL, "Maxillary sinus carcinomas: natural history and results of postoperative radiotherapy" 21 : 193-200, 1991

      6 Joosten M, "Management of the clinically node negative neck in squamous cell carcinoma of the maxilla" 66 : 87-92, 2017

      7 Katz TS, "Malignant tumors of the nasal cavity and paranasal sinuses" 24 : 821-829, 2002

      8 Homma A, "Lymph node metastasis in t4 maxillary sinus squamous cell carcinoma:incidence and treatment outcome" 21 : 1706-1710, 2014

      9 Le QT, "Lymph node metastasis in maxillary sinus carcinoma" 46 : 541-549, 2000

      10 Cantu G, "Lymph node metastases in malignant tumors of the paranasal sinuses: prognostic value and treatment" 134 : 170-177, 2008

      1 Kang JH, "Treatment outcomes between concurrent chemoradiotherapy and combination of surgery, radiotherapy, and/or chemotherapy in stage III and IV maxillary sinus cancer: multi-institutional retrospective analysis" 70 : 1717-1723, 2012

      2 Takes RP, "The controversy in the management of the N0 neck for squamous cell carcinoma of the maxillary sinus" 271 : 899-904, 2014

      3 Kuo P, "Survival outcomes for combined modality therapy for sinonasal undifferentiated carcinoma" 156 : 132-136, 2017

      4 Paulino AC, "Results of treatment of patients with maxillary sinus carcinoma" 83 : 457-465, 1998

      5 Jiang GL, "Maxillary sinus carcinomas: natural history and results of postoperative radiotherapy" 21 : 193-200, 1991

      6 Joosten M, "Management of the clinically node negative neck in squamous cell carcinoma of the maxilla" 66 : 87-92, 2017

      7 Katz TS, "Malignant tumors of the nasal cavity and paranasal sinuses" 24 : 821-829, 2002

      8 Homma A, "Lymph node metastasis in t4 maxillary sinus squamous cell carcinoma:incidence and treatment outcome" 21 : 1706-1710, 2014

      9 Le QT, "Lymph node metastasis in maxillary sinus carcinoma" 46 : 541-549, 2000

      10 Cantu G, "Lymph node metastases in malignant tumors of the paranasal sinuses: prognostic value and treatment" 134 : 170-177, 2008

      11 Paulino AC, "Is prophylactic neck irradiation indicated in patients with squamous cell carcinoma of the maxillary sinus?" 39 : 283-289, 1997

      12 박정현, "Is elective neck dissection needed in squamous cell carcinoma of maxilla?" 대한구강악안면외과학회 43 (43): 166-170, 2017

      13 Turner JH, "Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data" 34 : 877-885, 2012

      14 Jeon SH, "Implication of tumor location for lymph node metastasis in maxillary sinus carcinoma: indications for elective neck treatment" 75 : 858-866, 2017

      15 Jansen EP, "Does the combination of radiotherapy and debulking surgery favor survival in paranasal sinus carcinoma?" 48 : 27-35, 2000

      16 Gregoire V, "Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines" 110 : 172-181, 2014

      17 Jang NY, "Definitive radiotherapy with or without chemotherapy for T3-4N0 squamous cell carcinoma of the maxillary sinus and nasal cavity" 40 : 542-548, 2010

      18 Kim GE, "Clinical significance of neck node metastasis in squamous cell carcinoma of the maxillary antrum" 20 : 383-390, 1999

      19 Yang Z, "Cervical metastases from squamous cell carcinoma of hard palate and maxillary alveolus: a retrospective study of 10 years" 36 : 969-975, 2014

      20 Pezner RD, "Cervical lymph node metastases in patients with squamous cell carcinoma of the maxillary antrum: the role of elective irradiation of the clinically negative neck" 5 : 1977-1980, 1979

      21 Silverberg E, "Cancer statistics, 1970" 20 : 11-23, 1970

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2024 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2021-01-01 평가 등재학술지 선정 (해외등재 학술지 평가) KCI등재
      2020-12-01 평가 등재후보로 하락 (해외등재 학술지 평가) KCI등재후보
      2015-01-01 평가 SCOPUS 등재 (기타) KCI등재
      2013-01-01 평가 등재후보 1차 FAIL (등재후보1차) KCI등재후보
      2012-04-01 평가 등재후보로 하락 (기타) KCI등재후보
      2012-01-01 평가 등재후보학술지 유지 (기타) KCI등재후보
      2011-12-30 학회명변경 영문명 : The Korean Society For Therapeutic Radiology And Oncology -> The Korean Society for Radiation Oncology KCI등재
      2011-08-22 학술지명변경 한글명 : 대한방사선종양학회지 -> Radiation oncology journal
      외국어명 : The Journal of the Korean Society for Therapeutic Radiology and Oncology -> Radiation oncology journal
      KCI등재
      2009-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2006-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.31 0.31 0.25
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.23 0.22 0.864 0.05
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼